paper-with-me

홈 › Papers

AI-Driven Hybrid Ecological Model for Predicting Oncolytic Viral Therapy Dynamics

2025-01-18 · Abicumaran Uthamacumaran, Juri Kiyokawa, Hiroaki Wakimoto

Oncolytic viral therapy (OVT) is an emerging precision therapy for aggressive and recurrent cancers. However, its clinical efficacy is hindered by the complexity of tumor-virus-immune interactions and the lack of predictive models for personalized treatment. This study develops a data-driven, AI-powered computational model combining time-delayed Generalized Lotka-Volterra equations with advanced optimization algorithms, including Genetic Algorithms, Differential Evolution, and Reinforcement Learning, to optimize OVT oscillations' growth and damping. We hypothesize that the model can provide accurate, real-time predictions of OVT responses while identifying key biomarkers to enhance therapeutic efficacy. The model demonstrates strong predictive accuracy, achieving mean squared error (MSE) < 0.02 and R-squared > 0.82. It also identifies experimentally validated biomarkers such as TNF, NFkB, CD81, TRAF2, IL18, and BID, among other inflammatory cytokines and extracellular matrix reconstruction factors, despite being causally agnostic and unaware of specific experimental conditions or therapeutic combinations. Gene set enrichment analysis confirmed these biosignatures as critical predictors of tumor progression and indicated that photodynamic therapy activates immune responses similar to those elicited by combined OVT and immune checkpoint inhibitors. This hybrid model represents a significant step toward precision oncology and computational medicine, enabling longitudinal, adaptive treatment regimens and developing targeted immunotherapies based on molecular signatures, potentially improving patient outcomes.

📄 PDF Abstract BibTeX arXiv:2501.10620

Code (1)

Abicumaran/OVT 공식 구현

Methods 이 논문이 사용한 방법론

SET Dynamic Sparse Training method where weight mask is updated randomly periodically

Similar Papers 제목 키워드 기반

Oncolytic mechanisms and immunotherapeutic potential of Newcastle disease virus in cancer therapy

2025-05-09 · Umar Ahmad, Surializa Harun, Moussa Moise Diagne, Syahril Abdullah 외

Newcastle Disease Virus (NDV), classified as Avian orthoavulavirus 1 (avian paramyxovirus type 1), is a promising oncolytic agent that selectively targets and destroys cancer cells while sparing normal tissues. Its oncos…

Morphology classification

A hybrid discrete-continuum modelling approach for the interactions of the immune system with oncolytic viral infections

2024-04-09 · David Morselli, Marcello E. Delitala, Adrianne L. Jenner, Federico Frascoli

Oncolytic virotherapy, utilizing genetically modified viruses to combat cancer and trigger anti-cancer immune responses, has garnered significant attention in recent years. In our previous work arXiv:2305.12386, we devel…

A phenotype-structured mathematical model for the influence of hypoxia on oncolytic virotherapy

2024-10-20 · David Morselli, Giulia Chiari, Federico Frascoli, Marcello E. Delitala

The effectiveness of oncolytic virotherapy is significantly affected by several elements of the tumour microenvironment, which reduce the ability of the virus to infect cancer cells. In this work, we focus on the influen…

Agent-based and continuum models for spatial dynamics of infection by oncolytic viruses

2023-05-21 · David Morselli, Marcello Edoardo Delitala, Federico Frascoli

The use of oncolytic viruses as cancer treatment has received considerable attention in recent years, however the spatial dynamics of this viral infection is still poorly understood. We present here a stochastic agent-ba…

Mesenchymal stem cells as carrier cells to enable effective intratumoral delivery of oncolytic virus for oncolytic virotherapy: a systematic review

2022-04-04 · Chottiwatt Jittprasong

Oncolytic viruses, which may be naturally occurring or genetically engineered, are a type of virus that infects and destroy cancer cells preferentially. Owing to their selectivity, they outperform conventional chemothera…